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Edited by Jesus AvilaAbstract In order to evaluate links between Ca2+/calmodulin
(CaM)-dependent protein kinase type II (CaMK-II) and cell cy-
cle progression, CaMK-II binding partners were sought in prolif-
erating cells by epitope-tag tandem mass spectrometry. One
protein identiﬁed was the gelsolin family member, ﬂightless-I
(Fli-I). Fli-I is not a CaMK-II substrate, but binds directly
and preferentially to constitutively active (T287D) CaMK-II over
inactive CaMK-II. Fli-I gradually enters the nucleus upon
CaMK-II inhibition and is retained in the cytosol by T287D
CaMK-II. CaMK-II inhibition and Fli-I overexpression suppress
transcription of b-catenin dependent transcriptional reporters,
whereas Fli-I suppression enhances their transcription. These
ﬁndings support a novel mechanism whereby cytosolic CaMK-
II inﬂuences b-catenin dependent gene expression through Fli-I.
Structured summary:
MINT-6603828:
delta CaMK-II (uniprotkb:Q6PHZ2) binds (MI:0407) to
Flightless-I (uniprotkb:Q9JJ28) by anti bait coimmunoprecipi-
tation (MI:0006)
MINT-6603847:
delta CaMK-II (uniprotkb:Q6PHZ2) phosphorylates (MI:0217)
MAP2 (uniprotkb:P20357) by protein kinase assay (MI:0424)
MINT-6603768:
beta CaMK-II (uniprotkb:P28652) physically interacts
(MI:0218) with Flightless-I (uniprotkb:Q9JJ28) by anti bait
coimmunoprecipitation (MI:0006)
MINT-6603759, MINT-6603776, MINT-6603786:
delta CaMK-II (uniprotkb:Q6PHZ2) physically interacts
(MI:0218) with Flightless-I (uniprotkb:Q9JJ28) by anti bait
coimmunoprecipitation (MI:0006)
MINT-6603724:Abbreviations: CaMK-II, Ca2+/CaM-dependent protein kinase type II;
CaM, calmodulin; Fli-I, ﬂightless-I; Tcf/Lef, T-cell factor/lymphoid-
enhancer binding factor-1; GFP, green ﬂuorescent protein; AIP, auto-
inhibitory peptide
*Corresponding author. Address: Department of Biology, Virginia
Commonwealth University, 1000 West Cary Street, Richmond, VA
23284-2012, United States. Fax: +1 804 828 0503.
E-mail address: rtombes@vcu.edu (R.M. Tombes).
1Current address: Department of Cell Biology, University of Virginia,
Charlottesville, VA 22908, United States.
2Current address: Department of Obstetrics, Gynecology and Repro-
ductive Sciences, University of Pittsburgh, Pittsburgh, PA 15213,
United States.
0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2008.06.037CaMK-II delta (uniprotkb:Q6PHZ2) physically interacts
(MI:0218) with beta 5 tubulin (uniprotkb:P99024), beta 2c
tubulin (uniprotkb:P68372), alpha 1a tubulin (uniprotkb:
P68369), b-Actin (uniprotkb:P60710), Tropomodulin-3 (uni-
protkb:Q9JHJ0), Flightless-I (uniprotkb:Q9JJ28), FLAP1
(uniprotkb:Q3UZ39) and FLAP2 (uniprotkb:Q91WK0) by
anti tag coimmunoprecipitation (MI:0007)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: b-Catenin; CaMK-II; Mass spectrometry;
Flightless-I; Cyclin D1; Actin; Tubulin1. Introduction
The ‘‘multi-functional’’ Ca2+/calmodulin (CaM)-dependent
protein kinase type II (CaMK-II) [1,2] is twice as active in pro-
liferating cells as it is in growth-arrested cells and promotes cy-
clin D1 expression [3]. However, known cyclin D1
transcription factors are not activated by CaMK-II in these
cells [3] and nuclear-targeted CaMK-II splice variants are ab-
sent [4,5]. Therefore, an undetermined extra-nuclear mecha-
nism must link CaMK-II with cell cycle progression.
To identify potential regulatory pathways, binding partners
of cytosolic CaMK-II variants were sought. Among the pro-
teins identiﬁed was ﬂightless-I (Fli-I), a gelsolin related actin
binding and capping protein, which inﬂuences diverse pro-
cesses including cell migration and gene transcription [6,7].
Fli-I is a transcriptional co-activator of the estrogen and the
thyroid receptors [8], but suppresses b-catenin dependent pro-
moters [9]. It has been speculated that Fli-I links signal trans-
duction and cytoskeletal regulation [10,11], but the
mechanisms by which Fli-I translocates and then promotes
or inhibits transcription are unclear.
Both b-catenin dependent and independentWnt family mem-
bers inﬂuence cyclin D1 expression. Canonical Wnts induce the
accumulation of b-catenin, which promotes the expression of
T-cell factor/lymphoid-enhancer binding factor-1 (Tcf/Lef)-
dependent genes [12], such as cyclin D1. Some non-canonical
Wnts stimulate Ca2+ release, which then acts through CaMK-
II and PK-C to inﬂuence cell polarity and migration [13–15],blished by Elsevier B.V. All rights reserved.
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nin degradation [16,17] or suppressing cyclin D1 expression
[18]. This study provides evidence that CaMK-II inﬂuences b-
catenin dependent transcription and thus cell cycle progression
through an activity-dependent interaction with Fli-I.2. Materials and methods
2.1. Cell culture and harvest
NIH/3T3 cells were cultured, cell extracts were prepared, CaMK-II
activity was assayed and immunoblots were performed exactly as pre-
viously described [4,19,20].
2.2. Reagents
Ionomycin, KN-93, KN-92, and biotinylated CaM were obtained
from CalBiochem (La Jolla, CA). The CaMK-II auto-inhibitory pep-
tide (AIP) was from BioMol (Plymouth Meeting, PA). Fli-I and
FLAG polyclonal antibodies were from Covance (Princeton, NJ).
The mouse b CaMK-II antibody was from Invitrogen (Carlsbad,
CA). The goat d CaMK-II antibody and the rabbit green ﬂuorescent
protein (GFP) antibody were from Santa Cruz Biotechnology (Santa
Cruz, CA). Goat anti-mouse Texas red, biotinylated donkey anti-
mouse, anti-goat and anti-rabbit IgGs were from Kierkegaard Perry
Labs (Gaithersburg, MD). The rabbit actin antibody, the FLAG pep-
tide (DYKDDDDK) and M2 anti-FLAG agarose were from Sigma
(St. Louis, MO).
2.3. Vectors
The ‘‘FLAG’’ tag was linked to the amino terminus of wild type and
constitutively active GFP-CaMK-II cDNAs [20] as described [21]
(Fig. 1). GFP was linked to the amino terminus of human Fli-I cDNA
(obtained from OPEN Biosystems, Birmingham, AL). The cyclin D1
promoter-luciferase vector encompasses the ﬁrst 1 kb of the cyclin
D1 promoter [22]. FLAG-tagged human b-catenin was provided by
Dr. Barry Gumbiner, University of Virginia. The Super 8X TOPﬂash
vector was obtained from Addgene, Cambridge, MA [23]. All vectors
were analyzed by restriction digestion, DNA sequencing and activity
assays or immunoblots.
2.4. Transfections
Lipofectamine 2000 was used as recommended (Invitrogen) and cells
were sub-cultured, if necessary, to maintain sub-conﬂuence. For mass
spectrometry, 2 · 106 NIH/3T3 cells were typically co-transfected with
4 lg of FLAG vector and 8 lg of pBS-KS+, as carrier. cDNA amounts
were determined empirically to achieve sub-stoichiometric expression
relative to endogenous CaMK-II, thus maximizing the spectrum of
proteins identiﬁed.
2.5. FLAG immunoprecipitation and tandem mass spectrometry
Twenty-four hours after transfection, cells were harvested in Ca2+-
free buﬀer and 1 mg of lysate was subjected to anti-FLAG immunopre-
cipitation and elution with 0.2 mg/ml ‘‘FLAG’’ peptide as previously
described [21]. CaMK-II recovery varied between 10% and 40% of
the input CaMK-II and was conﬁrmed by anti-GFP immunoblots.
Tryptic peptides were prepared from FLAG eluents as described [21]
and then analyzed at either the University of Virginias W.M. Keck
Biomedical Mass Spectrometry Lab or at Virginia Commonwealth
Universitys Center for Biological Complexity. A partial list of binding
partners has been posted online (http://www.cellmigration.org/re-Fig. 1. FLAG-GFP-CaMK-II map. The FLAG-tag was linked to the
amino terminus of monomerized EGFP (mEGFP), which was
followed by the 316 residue catalytic and CaM binding domain, the
30 residue variable domain and the 132 residue association domain of
dC CaMK-II. Deletion constructs reﬂect these residues. Constitutively
active CaMK-II is achieved through a Thr287Asp mutation (arrow).source/proteomics/). At VCU, mass spectrometry was conducted using
a ThermoFinnigan LTQ XL linear ion trap mass spectrometer with
electron transfer dissociation (ETD) capability. Mass spectra were
searched against the murine database using Finnigan Bioworks v.3.2
(SEQUEST) and Peptide Prophet.
2.6. In vitro translation and immunoprecipitation
CaMK-II or Fli-I cDNAs were transcribed and translated using the
TnT coupled system (Promega, Madison, WI). About 100–200 lg of
total protein lysate or 100 ll of in vitro translated protein was immu-
noprecipitated as described [24] and then either assayed for CaMK-II
activity or prepared for SDS–PAGE.
2.7. Immunoblots
Immunoblots were normalized to loaded protein or initial protein
and conducted as previously described [20]. CaM overlays used 1 lg/
ml biotinylated CaM in 2 mM CaCl2 followed by 2 lg/ml alkaline
phosphatase-conjugated streptavidin (Jackson Labs, West Grove,
PA). Blots were digitally scanned and densitometry was performed
using Image J (National Institutes of Health).
2.8. CaMK-II partial puriﬁcation
GFP-CaMK-II was puriﬁed 50-fold by applying lysates in 2.6 mM
EGTA directly to a Superose-12 gel ﬁltration column (Amersham
Pharmacia, Piscataway, NJ). Pooled GFP ﬂuorescent fractions [25]
were made 1 mM in CaCl2 and then applied to a CaM-sepharose col-
umn. GFP-containing fractions were eluted with 2.6 mM EGTA,
pooled and concentrated with a Centricon-30 microconcentrator. Sam-
ples were stored at 80 C in 50% glycerol.
2.9. Immunolocalization
Cells were plated on glass cover slips, treated and then ﬁxed with 4%
formaldehyde and imaged by conventional ﬂuorescent microscopy as
previously described [24]. Anti-Fli-I IgG was used at 10 lg/ml. For
quantitation, regions of interest varied in size and shape, but always
encompassed at least 10000 pixels. Cytosolic regions were always peri-
nuclear. Fli-I staining intensity was averaged by digital image analysis
from at least 10 cells and at least 10 nuclear and perinuclear regions
within each cell.
2.10. Luciferase assays
5 · 105 NIH/3T3 cells were transfected with 3.0 lg total DNA which
consisted of cyclin D1-luciferase (1.0 lg), Super 8X TOPﬂash-lucifer-
ase (0.5 lg), wild type or S45A FLAG b-catenin (1.0 lg), GFP-Fli-I
(0.1–1.0 lg) and pBluescriptKS+. After 24–40 h, cells were harvested
and assayed in immediate triplicate, using the Moonlight Enhanced
Kit (BD Biosciences). Luciferase values were normalized to total pro-
tein and are represented as fold-activation.
2.11. siRNA
siRNAs (up to 100 pmol) were transfected with a total of 3.0 lg
pBluescriptKS+ or other DNA vectors into 5 · 105 NIH/3T3 cells
using Lipofectamine 2000 as described above. Two separate Fli-I siR-
NAs (Invitrogen) are listed (5 0 to 3 0) as follows: si-FliA,
CCGCCGAGUGGUACAACAUUGACUU and AAGUCAAUG
UUGUACCACUCGGCGG; si-FliB, ACGCCUUGACUACUCGG
AGUUCUUU and AAAGAACUCCGAGUAGUCAAGGCGU;
control siRNA, GCGCAGGAUUGAAGAAGAGCAGAAA and
UUUCUGCUCUUCUUCAAUCCUGCGC. Both siRNAs sup-
pressed Fli-I protein levels in a concentration-dependent manner, but
si-FliA was slightly more eﬀective and was used in all described exper-
iments.3. Results
3.1. Cytosolic CaMK-II binding partners
NIH/3T3 embryonic ﬁbroblasts express dC, dE and be
CaMK-II splice variants [2,4,5]. These isoforms are all cyto-
solic and are generated by alternative splicing of common
and unique exons in the central variable domain (Fig. 1). dC
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as it is encoded by only common exons in the variable domain
[2]. When linked to GFP, these CaMK-IIs retain their intracel-
lular location [25] and oligomerize properly [20]. In order to
screen for binding partners, a ‘‘FLAG’’ tag was linked to the
amino terminus of GFP-CaMK-II (Fig. 1), cells were transfec-
ted and CaMK-II was immunopuriﬁed. Proteins were thenTable 1
Cytosolic (dC) CaMK-II binding partners
Protein name Gene symbol Mr (kDa)
d CaMK-II CAMK2D 52
b5 tubulin TUBB5 50
b2c tubulin TUBB2C 50
a1a tubulin TUBA1A 50
b-Actin ACTB 43
Tropomodulin-3 TMOD3 40
Flightless-I FLII 145
FLAP1 LRRFIP1 89
FLAP2 LRRFIP2 82
The names, gene symbols, relative masses (Mr), average number of peptides de
that protein and the percentage of the entire protein sequence that was cove
Fig. 2. Interaction of CaMK-II and Fli-I. (A) Fli-I (145 kDa) immunoblot o
using anti-d CaMK-II (lane 2), anti-b CaMK-II (lane 3) and secondary anti
(lane 1) and Fli-I immunoprecipitate (200 lg cell lysate; lane 2). (C) Fli-I im
cells transfected with FLAG-GFP-tagged wild type dC CaMK-II (lane 1), FL
GFP-tagged wild type dC CaMK-II treated for 20 h with 10 lM KN-93 (lan
CaMK-II were determined by densitometry and are averaged over three separ
of dC CaMK-II after immunoprecipitation with anti-GFP; ratios of Fli-I to G
experiments. (E) Fli-I and GFP immunoblot of in vitro translated Fli-I, whi
wild type dC CaMK-II (lane 1) or FLAG-GFP-tagged constitutively active
FLAG IgG. These same immunoprecipitates and one ﬁfth of the volume of th
II was incubated in the presence of Ca2+/CaM and 32P-c-ATP for 30 min w
translated Fli-I (lane 4).identiﬁed by tandem mass spectrometry over seven replicate
analyses conducted between two mass spectrometry facilities
(Table 1). Heat shock proteins and keratins, were excluded.
Since highly conserved protein families, like CaMK-IIs and
tubulins, have a signiﬁcant fraction of identical peptides, only
proteins identiﬁed by their unique peptides are included. For
each protein, gene names, Mr, the average number of peptidesAverage peptide % unique % coverage
9.0 19 30.2
7.5 33 47.9
4.3 35 27.5
8.4 26 19.5
6.1 38 63.0
8.6 35 32.1
9.8 47 12.7
5.4 38 30.1
3.7 100 5.4
tected per analysis, the percentage of these peptides that were unique to
red by identiﬁed peptides are listed.
f 20 lg cell lysate (lane 1) and immunoprecipitates from 200 lg lysate
body alone (lane 4). (B) Biotinylated CaM overlay of 20 lg cell lysate
munoblot of anti-FLAG immunoprecipitates (200 lg cell lysate) from
AG-GFP-tagged constitutively active dC CaMK-II (lane 2) or FLAG-
e 3). CaMK-II levels were determined by anti-GFP. Ratios of Fli-I to
ate experiments. (D) Fli-I binding to full-length and deletion constructs
FP CaMK-II were determined by densitometry and averaged over three
ch had been mixed for 1 h with in vitro translated FLAG-GFP-tagged
dC CaMK-II (lanes 2 and 3) and then immunoprecipitated with anti-
e original reticulocyte lysate were probed for actin. (F) Puriﬁed CaMK-
ith no substrate (lanes 1 and 3), puriﬁed MAP2 (lane 2), or in vitro
2492 M.E. Seward et al. / FEBS Letters 582 (2008) 2489–2495identiﬁed per analysis, the percentage of predicted peptides
that were unique and the percentage of total protein coverage
are listed. In addition to CaMK-II itself, the binding proteins
identiﬁed included b5 tubulin, b2c tubulin, a1a tubulin, b
actin, tropomodulin-3, Fli-I, and two Fli-I associated proteins,
LRRFIP1 (FLAP1) and LRRFIP2 (FLAP2).
3.2. Endogenous Fli-I and CaMK-II interact
Although the interaction of CaMK-II with tubulins, actin
and actin binding proteins posed intriguing functional consid-
erations, the association of Fli-I was pursued in more detail in
this study. Endogenous Fli-I (145 kDa) and endogenous
CaMK-II interact as determined by reciprocal CaMK-II
(Fig. 2A) and Fli-I (Fig. 2B) immunoprecipitations. Approxi-
mately 25% of the input CaMK-II activity was recovered in
Fli-I immunoprecipitates. In transfected cells, constitutively
active dC CaMK-II (T
287D) co-precipitated approximately
10-fold more Fli-I (lane 2) than wild type CaMK-II cells (lane
1) treated with KN-93 (lane 3). None of the other CaMK-II-Fig. 3. Fli-I translocates to nucleus when CaMK-II is inhibited. Fli-I was lo
serum starvation, (B) return to serum-containing medium for 12 h in the ab
medium but treatment with 1 lM ionomycin. (E and F) At the indicated tim
(n > 10 for each time point) starved in serum-free medium (Starved), su
stimulated in the presence of KN-93 (Stim/KN-93), treated with KN-93 in ser
absence of serum (IONO).binding proteins demonstrated enhanced activity-dependent
binding. Fli-I binding was strongest with full-length CaMK-
II (Fig. 2D) when compared to truncated constructs, which en-
code the variable and association (311–478), the variable (311–
404) or association (339–478) domains alone [25].
3.3. CaMK-II directly binds, but does not phosphorylate Fli-I
To assess whether CaMK-II and Fli-I bind directly to each
other, FLAG-GFP dC CaMK-II and Fli-I cDNAs were
in vitro translated, then mixed and immunoprecipitated
(Fig. 2E). As with transfected CaMK-II, Fli-I preferentially
interacted with constitutively active (T287D, lane 2) over wild
type CaMK-II (WT, lane 1). Interestingly and as observed with
transfected CaMK-IIs [26], T287D CaMK-II was in vitro trans-
lated at about one third of the rate of wild type CaMK-II (data
not shown), presumably due to feedback translational inﬂu-
ences. Samples treated with AIP to block CaMK-II catalytic
activity only slightly decreased Fli-I binding to T287D
CaMK-II, indicating that persistent activity is not requiredcalized in NIH/3T3 cells by indirect immunoﬂuorescence after (A) 18 h
sence or (C) presence of 10 lM KN-93 or (D) retention in serum-free
e, the nuclear percentage of total ﬂuorescence was determined for cells
bsequently stimulated with serum-containing medium (Stimulated),
um-containing medium (KN-93) or treated with 1 lM ionomycin in the
Fig. 4. Fli-I is retained in cytosol by CaMK-II. GFP-Fli-I was
transfected alone (A and B) or with constitutively active (T287D) dC
CaMK-II (C) and then either maintained in (A) complete medium or
(B and C) serum starved for 18 h. Live conventional epiﬂuorescent
microscopy was used to image cells. Scale bar = 10 lm. (D) The
percentage of total ﬂuorescence that is nuclear was averaged from at
least 10 cells per condition and 10 regions of interest per cell. (E)
Twenty micrograms of lysate from untransfected (left lane) and GFP-
Fli-I transfected cells (right lane) were immunoblotted with anti-Fli-I.
Fli-I migrates at 145 kDa and GFP-Fli-I at 170 kDa.
M.E. Seward et al. / FEBS Letters 582 (2008) 2489–2495 2493for enhanced binding. Although the reticulocyte lysate, within
which in vitro translation was conducted, contained signiﬁcant
amounts of actin (retic lysate), actin did not persist in any of the
complexes assembled in vitro.
The microtubule associated protein, MAP2, is an excellent
substrate of partially puriﬁed CaMK-II (Fig. 2F, lane 2). How-
ever, neither in vitro translated Fli-I (lane 4) or immunoprecip-
itated Fli-I (not shown) were phosphorylated by CaMK-II,
even when gels were exposed for 10 times longer than the
MAP2 gel.
3.4. Fli-I enters the nucleus upon CaMK-II inhibition
Fli-I gradually accumulates in the nucleus as cells reach con-
ﬂuence [27] and upon serum deprivation (Fig. 3A). When
starved cells were serum-stimulated, cytosolic Fli-I was ob-
served in association with ﬁbrous elements in the perinuclear
region (Fig. 3B). If serum-stimulation was conducted in the
presence of KN-93, Fli-I remained in the nucleus (Fig. 3C).
Similarly, KN-93 treatment of cells in serum resulted in the
gradual nuclear accumulation of Fli-I. Cells maintained in ser-
um-free medium, but treated with the Ca2+ ionophore, iono-
mycin, also resulted in a gradual nuclear export of Fli-I
(Fig. 3D). Translocation kinetics demonstrated that Fli-I nu-
clear accumulation (Fig. 3E) requires 8–10 h to complete
whether by starvation or CaMK-II inhibition. Fli-I nuclear
export was also a gradual process, requiring 3–6 h (Fig. 3F).
KN-93 is the only CaMK-II inhibitor eﬀective in these cells
over this time period, since membrane-permeant derivatives
of AIP (myr-AIP) have a short half-life of 3 h [24] and
CaMK-II is relatively stable in NIH/3T3 cells. In these cells,
neither dominant negative constructs nor siRNAs signiﬁcantly
interfered with CaMK-II, even though they are eﬀective in
other cell types [26,28]. Live cell imaging of GFP-Fli-I was
next conducted because constitutively active CaMK-II trans-
fected cells are less adherent and do not remain attached
through immunostaining. GFP-Fli-I translocated from the
cytosol (Fig. 4A) to the nucleus after 18 h of serum starvation
(Fig. 4B) unless constitutively active CaMK-II was co-trans-
fected (Fig. 4C). Quantitation reveals the relative, not com-
plete, retention of Fli-I by constitutively active CaMK-II in
the cytosol (Fig. 4D). GFP-Fli-I is shown at the expected Mr
and abundance relative to endogenous Fli-I (Fig. 4E).
3.5. Fli-I suppresses transcription
The inﬂuences of CaMK-II activity and Fli-I expression
were next evaluated using the Super TOPﬂash-luc (TOPﬂash)
and the cyclin D1-luc vectors. Fli-I induced a dose-dependent
inhibition of transcription whether wild type or degradation
resistant (S45A) b-catenin was used (Fig. 5A). TOPﬂash was
inhibited by KN-93 in the same dose-dependent manner as it
blocks G1-phase cell cycle progression [3,4]. Like Fli-I, KN-
93 inhibited transcription regardless of whether wild type or
non-degradable b-catenin was used. Furthermore, wild type
FLAG b-catenin was not diminished in cells treated with
10 lMKN-93 (inset, Fig. 5A). Cyclin D1-luc expression exhib-
ited similar sensitivity to Fli-I and KN-93 (Fig. 5B). In comple-
mentary ﬁndings, two separate Fli-I siRNA oligonucleotide
pairs caused a dose-dependent decrease in Fli-I protein levels
and b-catenin-independent increase in cyclin D1-luc transcrip-
tion; one of these is shown (Fig. 5C). Co-transfected GFP-Fli-I
reversed siRNA eﬀects (Fig. 5C). Relative levels of endogenous
and transfected Fli-I are shown.4. Discussion
Of the CaMK-II binding proteins identiﬁed in this study,
only actin and tubulin had previously been reported [24,29].
This is not surprising since CaMK-II co-localizes with the ac-
tin cytoskeleton and inﬂuences cytoskeletal and focal adhesion
dynamics [24,25,29–31]. Certain CaMK-IIs bind more strongly
to actin stress-ﬁbers than other variants [30], but those CaMK-
IIs were not used in this study and are not expressed in these
cells. The actin–CaMK-II interaction characterized in this
and previous studies [25] may be mediated by the actin binding
proteins identiﬁed here. Amongst the CaMK-II binding part-
ners, b5 tubulin (class V) has a functionally distinct role from
other tubulins in microtubule fragmentation and paclitaxel
resistance [32] and tropomodulin-3 acts diﬀerently from other
tropomodulins in regulating cell migration and cell height [33].
Proteins other than Fli-I have also been shown to bind pref-
erentially to the activated state of CaMK-II, including histone
deacetylase-4 [34] and the glutamate receptor [35]. Auto-phos-
phorylation is believed to inﬂuence the overall structure of
CaMK-II [36], by expanding the core of the CaMK-II holoen-
zyme, thus exposing potential binding sites or placing CaMK-
II in the proper spatial context to bind to extended proteins
like Fli-I. In proliferating cells, Fli-I and CaMK-II co-localize
in the perinuclear region [25,27]. It is possible that when Fli-I is
bound to CaMK-II, the putative nuclear targeting sequence
(K1035RKFIIHRGKRK1046) is obstructed, preventing the for-
mation of a nuclear import complex. The serum-induced sig-
nals that lead to Fli-I nuclear export are unknown [27].
Fig. 5. CaMK-II acts through Fli-I to suppress cyclin D1 transcrip-
tion. Luciferase assays and immunoblots were performed 40 h after
transient transfection of 5 · 105 NIH/3T3 cells in complete medium.
Cells were plated so that cultures remained subconﬂuent. When
indicated, KN-93 (ﬁnal lM, as indicated) was included only during the
last 24 h before harvest. (A and B) Fold-activation of luciferase was
determined after cells were co-transfected with 1 lg FLAG-b-catenin
(WT or S45A), 0.5 lg TOPﬂash-luc or 1.0 lg cyclin D1-luc and the
indicated amount (lg) of GFP-Fli-I. (A: inset) Anti-FLAG immuno-
blot of WT FLAG-b-catenin in cells treated with 0 and 10 lMKN-93.
(C) Fli-I and control siRNAs (indicated in pmol; pm) were co-
transfected with 1 lg cyclin D1-luc or the indicated lg of GFP-Fli-I,
but not b-catenin. Luciferase values are represented as fold-activation
relative to cells transfected with cyclin D1-luc alone. Anti-Fli-I
immunoblot shows the relative levels of endogenous and transfected
Fli-I.
2494 M.E. Seward et al. / FEBS Letters 582 (2008) 2489–2495The interaction of CaMK-II with Fli-I provides the most
plausible current explanation by which CaMK-II promotes cy-
clin D1 expression and cell cycle progression [3,4,37]. Our ﬁnd-
ings demonstrate that Fli-I suppresses the b-catenin dependent
transcription of both TOPﬂash and cyclin D1 reporters with-
out inducing b-catenin degradation. Fli-I has been proposed
to interfere with transcription by competing with b-catenin
and FLAP1, an activator of Tcf/Lef-dependent genes [9] and
FLAP2 was shown to be a positive eﬀector of the canonical
Wnt pathway through its interaction with Disheveled (Dvl)
[38]. FLAP1 and FLAP2 were both detected in our screen
for CaMK-II binding partners. Evidence suggests that the
transcription of b-catenin dependent genes is inﬂuenced bysubtle changes in the ratio of Fli-I, b-catenin, FLAPs and
Tcf/Lef factors. CaMK-II has also been reported to aﬀect b-
catenin dependent transcription by promoting the export of
Tcf [39,40]. It remains to be determined, whether CaMK-II
simultaneously inﬂuences b-catenin dependent genes through
both Fli-I and Tcf localization.
This study provides evidence for a novel, straightforward
mechanism by which Ca2+, acting through CaMK-II, can di-
rectly inﬂuence the expression of b-catenin dependent genes
without entering the nucleus. In proliferating cells, total cellu-
lar CaMK-II is active and therefore sequesters Fli-I in the
cytosol. As cells reach conﬂuence, Ca2+ transients subside,
CaMK-II becomes less active, and cells stop migrating, as fo-
cal adhesions are no longer turned over [31]. Fli-I gradually
dissociates from CaMK-II, as it progressively becomes inac-
tive, to enter the nucleus where it suppresses the transcription
of b-catenin dependent genes, such as cyclin D1. Fli-I inﬂu-
ences cell proliferation throughout the life cycle including dur-
ing embryogenesis [41]. The interaction of Fli-I with CaMK-II
represents a plausible link between contact-dependent growth
inhibition and b-catenin dependent transcription. The interac-
tion of Fli-I with CaMK-II also represents a means by which
cross-talk could occur between ‘‘canonical’’ and ‘‘non-canoni-
cal’’ (Ca2+-dependent) Wnt pathways during development and
through which cytosolic Ca2+ signaling could inﬂuence the
canonical Wnt pathway and thus inﬂuence proliferation deci-
sions.
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